Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker DK
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Russell Amber Officer | DK Delek US Holdings, Inc. | 5,392 | $407.1K | — | Sep 11, 2026 | Form 4 ↗ 4 days later · 5,392 shares | Form 144 ↗ |
| Sep 11, 2026 | William J & Judith M Finnerty Trust Director | DK Delek US Holdings, Inc. | 2,943 | $227.1K | — | Sep 11, 2026 | Form 4 ↗ 4 days later · 2,943 shares | Form 144 ↗ |
| Sep 4, 2026 | Sutil Vicky Director | DK Delek US Holdings, Inc. | 6,397 | $457.4K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ 5 days later · 6,397 shares | Form 144 ↗ |
| Sep 1, 2026 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 7,500 | $549.1K | — | Sep 1, 2026 | Form 4 ↗ 2 days later · 7,500 shares | Form 144 ↗ |
| Aug 28, 2026 | Richard J. Marcogliese Director | DK Delek US Holdings, Inc. | 2,000 | $142.1K | — | Aug 21, 2026 | — | Form 144 ↗ |
| Aug 24, 2026 | Gary M. Sullivan Jr. Director | DK Delek US Holdings, Inc. | 27,688 | $1.9M | — | Aug 24, 2026 | Form 4 ↗ 2 days later · 27,688 shares | Form 144 ↗ |
| Aug 21, 2026 | William J. Finnerty Director | DK Delek US Holdings, Inc. | 1,457 | $94.3K | — | Aug 21, 2026 | Form 4 ↗ 4 days later · 1,457 shares | Form 144 ↗ |
| Aug 18, 2026 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 10,000 | $682.1K | 10b5-1 | Aug 18, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Aug 17, 2026 | Hobbs Mark Wayne Officer | DK Delek US Holdings, Inc. | 20,000 | $1.3M | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 1 day later · 20,000 shares | Form 144 ↗ |
| Aug 17, 2026 | Soreq Avigal Officer, Director | DK Delek US Holdings, Inc. | 80,000 | $5.2M | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 1 day later · 80,000 shares | Form 144 ↗ |
| Aug 13, 2026 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 200,000 | $13.4M | 10b5-1 | Aug 13, 2026 | Form 4 ↗ 4 days later · 200,000 shares | Form 144 ↗ |
| Jun 29, 2026 | William J. Finnerty Director | DK Delek US Holdings, Inc. | 5,000 | $239.1K | 10b5-1 | Jun 29, 2026 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Jun 5, 2026 | Joseph Israel Former Officer | DK Delek US Holdings, Inc. | 13,777 | $682.0K | — | Jun 5, 2026 | — | Form 144 ↗ |
| Jun 3, 2026 | Sutil Vicky Director | DK Delek US Holdings, Inc. | 1,871 | $89.8K | — | Jun 3, 2026 | Form 4 ↗ 2 days later · 1,871 shares | Form 144 ↗ |
| Jun 1, 2026 | Sutil Vicky Director | DK Delek US Holdings, Inc. | 3,061 | $140.8K | — | Jun 1, 2026 | Form 4 ↗ 1 day later · 4,909 shares | Form 144 ↗ |
| May 29, 2026 | Sutil Vicky Director | DK Delek US Holdings, Inc. | 1,848 | $83.2K | — | May 29, 2026 | Form 4 ↗ 4 days later · 4,909 shares | Form 144 ↗ |
| May 28, 2026 | Sutil Vicky Director | DK Delek US Holdings, Inc. | 1,849 | $81.4K | — | May 28, 2026 | Form 4 ↗ 4 days later · 1,849 shares | Form 144 ↗ |
| May 18, 2026 | Laurie Z. Tolson Director | DK Delek US Holdings, Inc. | 4,921 | $227.8K | — | May 18, 2026 | Form 4 ↗ 2 days later · 4,921 shares | Form 144 ↗ |
| May 18, 2026 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 10,000 | $443.6K | 10b5-1 | May 18, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| May 13, 2026 | Robert G. Wright Officer | DK Delek US Holdings, Inc. | 10,720 | $504.6K | — | May 13, 2026 | Form 4 ↗ 2 days later · 10,720 shares | Form 144 ↗ |
| Apr 29, 2026 | Joseph Israel Former Officer | DK Delek US Holdings, Inc. | 30,260 | $1.4M | — | Apr 29, 2026 | — | Form 144 ↗ |
| Mar 27, 2026 | William J. Finnerty Director | DK Delek US Holdings, Inc. | 5,000 | $232.1K | 10b5-1 | Mar 27, 2026 | Form 4 ↗ 4 days later · 5,000 shares | Form 144 ↗ |
| Mar 19, 2026 | Zohar Shlomo Director | DK Delek US Holdings, Inc. | 7,343 | $337.8K | 10b5-1 | Mar 19, 2026 | Form 4 ↗ 4 days later · 7,343 shares | Form 144 ↗ |
| Mar 18, 2026 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 161,764 | $6.8M | 10b5-1 | Mar 18, 2026 | Form 4 ↗ 2 days later · 55,356 shares | Form 144 ↗ |
| Mar 18, 2026 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 33,586 | $1.4M | 10b5-1 | Mar 18, 2026 | Form 4 ↗ 2 days later · 55,356 shares | Form 144 ↗ |
| Mar 18, 2026 | William J. Finnerty Director | DK Delek US Holdings, Inc. | 5,000 | $211.7K | 10b5-1 | Mar 18, 2026 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Mar 13, 2026 | McWatters Denise Clark Officer | DK Delek US Holdings, Inc. | 11,988 | $495.5K | — | Mar 13, 2026 | Form 4 ↗ 4 days later · 11,988 shares | Form 144 ↗ |
| Mar 9, 2026 | Zohar Shlomo Director | DK Delek US Holdings, Inc. | 5,000 | $207.3K | — | Mar 9, 2026 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Mar 5, 2026 | Zohar Shlomo Director | DK Delek US Holdings, Inc. | 22,029 | $987.6K | 10b5-1 | Mar 5, 2026 | Form 4 ↗ 1 day later · 29,372 shares | Form 144 ↗ |
| Mar 4, 2026 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 18,139 | $727.4K | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 84,650 shares | Form 144 ↗ |
| Mar 4, 2026 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 66,511 | $2.7M | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 84,650 shares | Form 144 ↗ |
| Mar 4, 2026 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 20,000 | $856.9K | — | Mar 4, 2026 | Form 4 ↗ 2 days later · 20,000 shares | Form 144 ↗ |
| Mar 4, 2026 | Zohar Shlomo Director | DK Delek US Holdings, Inc. | 7,343 | $315.7K | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 29,372 shares | Form 144 ↗ |
| Mar 4, 2026 | William J. Finnerty Director | DK Delek US Holdings, Inc. | 5,392 | $230.5K | — | Mar 4, 2026 | Form 4 ↗ 2 days later · 5,392 shares | Form 144 ↗ |
| Mar 4, 2026 | Joseph Israel OFFICER | DK Delek US Holdings, Inc. | 38,000 | $1.5M | — | Mar 4, 2026 | Form 4 ↗ 2 days later · 38,000 shares | Form 144 ↗ |
| Mar 3, 2026 | Soreq Avigal Officer, Director | DK Delek US Holdings, Inc. | 50,000 | $2.1M | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 2 days later · 50,000 shares | Form 144 ↗ |
| Nov 12, 2025 | Robert G. Wright Officer | DK Delek US Holdings, Inc. | 2,303 | $93.1K | — | Nov 12, 2025 | Form 4 ↗ 1 day later · 7,946 shares | Form 144 ↗ |
| Nov 12, 2025 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 17,000 | $704.0K | — | Nov 11, 2025 | Form 4 ↗ 1 day later · 27,000 shares | Form 144 ↗ |
| Nov 12, 2025 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 10,000 | $414.1K | 10b5-1 | Nov 11, 2025 | Form 4 ↗ 1 day later · 27,000 shares | Form 144 ↗ |
| Nov 12, 2025 | Robert G. Wright Officer | DK Delek US Holdings, Inc. | 5,643 | $234.0K | — | Nov 11, 2025 | Form 4 ↗ 1 day later · 7,946 shares | Form 144 ↗ |
| Nov 12, 2025 | Joseph Israel OFFICER | DK Delek US Holdings, Inc. | 28,494 | $1.2M | — | Nov 11, 2025 | Form 4 ↗ 1 day later · 24,408 shares | Form 144 ↗ |
| Nov 7, 2025 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 30,000 | $1.3M | 10b5-1 | Nov 7, 2025 | Form 4 ↗ 5 days later · 55,350 shares | Form 144 ↗ |
| Nov 7, 2025 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 110,000 | $4.7M | 10b5-1 | Nov 7, 2025 | Form 4 ↗ 5 days later · 55,350 shares | Form 144 ↗ |
| Oct 23, 2025 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 110,000 | $4.2M | 10b5-1 | Oct 23, 2025 | Form 4 ↗ 4 days later · 132,612 shares | Form 144 ↗ |
| Oct 23, 2025 | Ezra Uzi Yemin Officer, Director | DK Delek US Holdings, Inc. | 30,000 | $1.1M | 10b5-1 | Oct 23, 2025 | Form 4 ↗ 4 days later · 132,612 shares | Form 144 ↗ |
| Sep 2, 2025 | Robert G. Wright Officer | DK Delek US Holdings, Inc. | 7,135 | $208.7K | — | Sep 2, 2025 | Form 4 ↗ 2 days later · 7,135 shares | Form 144 ↗ |
| Jul 7, 2025 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 700 | $16.8K | 10b5-1 | Jul 7, 2025 | Form 4 ↗ 2 days later · 700 shares | Form 144 ↗ |
| Aug 8, 2024 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 750 | $15.3K | 10b5-1 | Aug 8, 2024 | — | Form 144 ↗ |
| Jul 8, 2024 | Spiegel Reuven Officer | DK Delek US Holdings, Inc. | 750 | $17.7K | 10b5-1 | Jul 8, 2024 | — | Form 144 ↗ |
| Jun 10, 2024 | Laurie Z. Tolson Director | DK Delek US Holdings, Inc. | 604 | $14.6K | 10b5-1 | Jun 10, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances